Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing
Search jobs 20-Apr-2021 Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing Half of All Patients With NSCLC Have Oncogene Mutations, Yet Many Patients Are Not Tested to Screen for Biomarkers Professional Clinical Guidelines Recommend Broad Biomarker Testing for Actionable and Emerging Biomarkers, Including KRAS Biomarker Assist™ May Provide Eligible Patients Savings on Biomarker Testing Amgen (NASDAQ: AMGN) today announced the launch of Biomarker Assist™, a progr...
Source: pharmiweb.com